toggle visibility Search & Display Options

Select All    Deselect All
 | 
Citations
 | 
   print
Oliva, C. R., Zhang, W., Langford, C., Suto, M. J., & Griguer, C. E. (2017). Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit. Oncotarget, 8(23), 37568–37583.
toggle visibility
Roy, A., Attarha, S., Weishaupt, H., Edqvist, P. - H., Swartling, F. J., Bergqvist, M., et al. (2017). Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression. Oncotarget, 8(15), 24815–24827.
toggle visibility
Brodie, S., Lee, H. K., Jiang, W., Cazacu, S., Xiang, C., Poisson, L. M., et al. (2017). The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells. Oncotarget, 8(19), 31785–31801.
toggle visibility
Sullivan, K. E., Rojas, K., Cerione, R. A., Nakano, I., & Wilson, K. F. (2017). The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells. Oncotarget, 8(14), 22325–22343.
toggle visibility
Glaser, T., Han, I., Wu, L., & Zeng, X. (2017). Targeted Nanotechnology in Glioblastoma Multiforme. Front Pharmacol, 8, 166.
toggle visibility
Select All    Deselect All
 | 
Citations
 | 
   print